Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Objective: To assess psychotropic drug utilization in the general population of six European countries, and the pattern of use in individuals with different DSM‐IV diagnoses of 12‐month mental disorders. Method: Data were derived from the European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000), a cross‐sectional psychiatric epidemiological study in a representative sample of 21 425 adults aged 18 or older from six European countries (e.g. Belgium, France, Germany, Italy, the Netherlands and Spain). Individuals were asked about any psychotropic drug use in the past 12 months, even if they used the drug(s) just once. A colour booklet containing high‐quality pictures of psychotropic drugs commonly used to treat mental disorders was provided to help respondents recall drug use. Results: Psychotropic drug utilization is generally low in individuals with any 12‐month mental disorder (32.6%). The extent of psychotropic drug utilization varied according to the specific DSM‐IV diagnosis. Among individuals with a 12‐month diagnosis of pure major depression, only 21.2% had received any antidepressants within the same period; the exclusive use of antidepressants was even lower (4.6%), while more individuals took only anxiolytics (18.4%). Conclusion: These data question the appropriateness of current pharmacological treatments, particularly for major depression, in which under‐treatment is coupled with the high use of non‐specific medications, such as anxiolytics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ohayon, M. M., & Lader, M. H. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0912 · Cited by 271
Tylee, A., Gastpar, M., Lépine, J. P., & Mendlewicz, J. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199905002-00001 · Cited by 221
Self-citationSampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project
The ESEMeD/MHEDEA 2000 investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00326 · Cited by 211
Self-citationGender Bias in Psychotropic Drug Prescribing in Primary Care
Hohmann, A. A. (1989) · Medical Care · doi:10.1097/00005650-198905000-00004 · Cited by 137
Research on psychotropic drug use
Cooperstock, R., & Parnell, P. (1982) · Social Science & Medicine · doi:10.1016/0277-9536(82)90143-5 · Cited by 111
Allgulander, C. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.8.1006 · Cited by 109
Different study criteria affect the prevalence of benzodiazepine use
Zandstra, S. M., Furer, J. W., van de Lisdonk, E. H., Hof, M. V., Bor, J. H., van Weel, C., & Zitman, F. G. (2002) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270200006 · Cited by 109
Patterns of Psychotherapeutic Drug Use Among Adults in San Francisco
Mellinger, G. D., Balter, M. B., & Manheimer, D. I. (1971) · Archives of General Psychiatry · doi:10.1001/archpsyc.1971.01750170001001 · Cited by 105
Psychotropic-Drug Prescribing for Women
Ashton, H. (1991) · The British Journal of Psychiatry · doi:10.1192/s0007125000291964 · Cited by 86
Spijker, J., Bijl, R. V., de Graaf, R., & Nolen, W. A. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00363.x · Cited by 85
Cited by
Alonso, J., Angermeyer, M. C., & Lépine, J. P. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00325.x · Cited by 758
Self-citationRuss, T. C., Stamatakis, E., Hamer, M., Starr, J. M., Kivimaki, M., & Batty, G. D. (2012) · BMJ · doi:10.1136/bmj.e4933 · Cited by 637
Unemployment and Substance Use: A Review of the Literature (1990-2010)
Henkel, D. (2011) · Current Drug Abuse Reviewse · doi:10.2174/1874473711104010004 · Cited by 590
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Jeronimus, B. F., Kotov, R., Riese, H., & Ormel, J. (2016) · Psychological Medicine · doi:10.1017/s0033291716001653 · Cited by 360
Self-citationSpinhoven, P., Elzinga, B. M., Hovens, J. G. F. M., Roelofs, K., Zitman, F. G., van Oppen, P., & Penninx, B. W. J. H. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.132 · Cited by 324
Millan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 283
Van Reedt Dortland, A. K. B., Giltay, E. J., Van Veen, T., Zitman, F. G., & Penninx, B. W. J. H. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01565.x · Cited by 191
Bauer, M., Monz, B. U., Montejo, A. L., Quail, D., Dantchev, N., Demyttenaere, K., Garcia-Cebrian, A., Grassi, L., Perahia, D. G. S., Reed, C., et al. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2007.11.001 · Cited by 186
Self-citationKarsten, J., Hartman, C. A., Smit, J. H., Zitman, F. G., Beekman, A. T. F., Cuijpers, P., van der Does, A. J. W., Ormel, J., Nolen, W. A., & Penninx, B. W. J. H. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.080572 · Cited by 155
Self-citationLewer, D., O'Reilly, C., Mojtabai, R., & Evans-Lacko, S. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156786 · Cited by 150
Genetic and environmental influences on psychiatric comorbidity: a systematic review.
Cerdá, M., Sagdeo, A., Johnson, J., & Galea, S. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.11.006 · Cited by 131
Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys
Merikangas, K. R., & Kalaydjian, A. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3281c61dc5 · Cited by 122
Child abuse and health-related quality of life in adulthood
Afifi, T. O., Enns, M. W., Cox, B. J., de Graaf, R., ten Have, M., & Sareen, J. (2007) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3181567fdd · Cited by 122
“…found that psychiatric disorders and chronic physical health conditions have strong associations with reduced functioning and decreased quality of life (Alonso et al., 2004a,b; Kessler et al., 2003; Kruijshaar et al., 2003; Mendlowicz and Stein, 2000; Stein and Kean, 2000; Zayfert et al., 2002).”
BackgroundAnsseau, M., Fischler, B., Dierick, M., Albert, A., Leyman, S., & Mignon, A. (2008) · Depression and Anxiety · doi:10.1002/da.20306 · Cited by 114
Bulbena, A., Gago, J., Pailhez, G., Sperry, L., Fullana, M. A., & Vilarroya, O. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.03.004 · Cited by 113
Benzodiazepine dependence: Focus on withdrawal syndrome
Authier, N., Balayssac, D., Sautereau, M., Zangarelli, A., Courty, P., Somogyi, A. A., Vennat, B., Llorca, P.-M., & Eschalier, A. (2009) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2009.07.001 · Cited by 79
Use of health services for major depressive and anxiety disorders in Finland
Hämäläinen, J., Isometsä, E., Sihvo, S., Pirkola, S., & Kiviruusu, O. (2008) · Depression and Anxiety · doi:10.1002/da.20256 · Cited by 64
Morbidity in depressive disorders
Baldessarini, R. J., Forte, A., Selle, V., Sim, K., Tondo, L., Undurraga, J., & Vázquez, G. H. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448661 · Cited by 63
Eiring, Ø., Landmark, B. F., Aas, E., Salkeld, G., Nylenna, M., & Nytrøen, K. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007848 · Cited by 57
Cerdá, M., DiGangi, J., Galea, S., & Koenen, K. (2012) · Depression and Anxiety · doi:10.1002/da.21947 · Cited by 34
Carlino, D., Francavilla, R., Baj, G., Kulak, K., d’Adamo, P., Ulivi, S., Cappellani, S., Gasparini, P., & Tongiorgi, E. (2015) · PeerJ · doi:10.7717/peerj.1252 · Cited by 23
Aumento da utilização de benzodiazepínicos entre idosos mais velhos: Projeto Bambuí
Oliveira, A. L. M. L., Nascimento, M. M. G. D., Castro-Costa, É., Firmo, J. O. A., Lima-Costa, M. F., & Loyola Filho, A. I. D. (2020) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-549720200029 · Cited by 17
Maron, E., Lan, C.-C., & Nutt, D. (2018) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2018_49 · Cited by 9
Metadata
- Authors
- The ESEMeD/MHEDEA 2000 investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., Gasquet, I., Haro, J. M., Katz, S. J., Kessler, R. C., Kovess, V., Lépine, J. P., Ormel, J., Polidori, G., Russo, L. J., Vilagut, G., Almansa, J., Arbabzadeh‐Bouchez, S., Autonell, J., Bernal, M., Buist‐Bouwman, M. A., Codony, M., Domingo‐Salvany, A., Ferrer, M., Joo, S. S., Martínez‐Alonso, M., Matschinger, H., Mazzi, F., Morgan, Z., Morosini, P., Palacín, C., Romera, B., Taub, N., & Vollebergh, W. A. M.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2004-06
- Volume
- 109
- Issue
- s420
- Pages
- 55-64
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2063378887
- Cited by
- 314
- References
- 23
- FWCI
- 25.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.